Ataia Medical Company Profile

Background

Overview:
Ataia Medical, founded in 2017, specializes in developing communication solutions for patients undergoing non-invasive ventilation. Their flagship product, the SPEAX Communication System, enables patients to communicate verbally without interrupting their therapy. This innovation addresses a critical need in healthcare by facilitating clear communication between patients, caregivers, and loved ones during ventilation treatments.

Mission and Vision:
Ataia Medical is committed to empowering patients and healthcare providers with the freedom to communicate effectively, enhancing patient care and safety during non-invasive ventilation therapies.

Industry Significance:
By focusing on communication solutions for ventilated patients, Ataia Medical contributes significantly to improving patient outcomes and experiences in critical care settings.

Key Strategic Focus

Core Objectives:

Develop and provide innovative communication tools for non-invasive ventilation patients.

Enhance patient engagement and participation in their care.

Improve overall patient safety and satisfaction during ventilation therapy.

Areas of Specialization:

Medical device development for communication during non-invasive ventilation.

Integration of communication systems with existing respiratory therapies.

Key Technologies Utilized:

SPEAX Communication System: A two-part system comprising a reusable communicator and a disposable patch that attaches to ventilation masks, enabling clear verbal communication.

Primary Markets Targeted:

Hospitals and critical care units.

Home healthcare settings for patients using CPAP and BiPAP devices.

Financials and Funding

Funding History:
Ataia Medical has raised a total of $330,000 in funding. Notable funding rounds include:

Seed Round (July 2018): $300,000 from investors such as Green Park & Golf Ventures and angel investors specializing in medical devices.

Grant (May 2020): $5,000 to support further development.

Notable Investors:

Grant Park Ventures

Green Park & Golf Ventures

Health Wildcatters

Advanced Technology Development Center

Portland State University Business Accelerator

Utilization of Capital:
The funds have been allocated towards product development, securing FDA clearance, and expanding market reach.

Pipeline Development

Key Product:

SPEAX Communication System: Designed to enable verbal communication for patients on non-invasive ventilation without interrupting therapy.

Development Stages:

Product development and testing completed.

Efforts focused on securing FDA clearance and market introduction.

Target Conditions:

Patients requiring non-invasive ventilation, including those using CPAP and BiPAP devices.

Anticipated Milestones:

FDA clearance.

Commercial launch in hospital and home healthcare markets.

Technological Platform and Innovation

Proprietary Technologies:

SPEAX Communication System: A patented two-part system consisting of a reusable communicator and a disposable patch that attaches to ventilation masks, facilitating clear verbal communication.

Scientific Methodologies:

Development of non-invasive communication aids compatible with existing respiratory therapies.

Leadership Team

Tyler Register: Co-Founder and Chief Executive Officer.

Background: Biomedical engineering graduate from Georgia Tech.

Role: Oversees company strategy, product development, and operations.

Amy Foertsch: Co-Founder and Chief Operating Officer.

Background: Biomedical engineering graduate from Georgia Tech.

Role: Manages daily operations and product development processes.

A. Ian Wong, MD: Co-Founder and Chief Medical Officer.

Background: Critical care fellow physician at Emory University.

Role: Provides medical expertise and oversees clinical aspects of product development.

Amber Jackson: Co-Founder, Co-Chief Operations Officer, Chief Commercial Officer, and Chief Marketing Officer.

Role: Leads commercial strategy and marketing initiatives.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within the company's leadership team.

Competitor Profile

Market Insights and Dynamics:
The medical devices market, particularly in the respiratory care segment, is experiencing growth due to increasing prevalence of respiratory conditions and advancements in non-invasive ventilation technologies.

Competitor Analysis:

Atos Medical: Specializes in medical devices for tracheostomy care, offering products that facilitate communication for patients with airway issues.

Reprieve Cardiovascular: Develops medical devices focused on cardiovascular care, with some overlap in patient monitoring and communication solutions.

Liberate Medical: Focuses on respiratory muscle stimulation devices, indirectly competing in the respiratory care market.

Strategic Collaborations and Partnerships

Ataia Medical has engaged with several accelerators and incubators to strengthen its market position and innovation capacity:

Health Wildcatters: Participated in this medical device accelerator to gain mentorship and refine product design.

Tricera Labs: Joined this medical technology incubator in Dallas, TX, focusing on product development and FDA clearance.

Operational Insights

Strategic Considerations:

Market Position: Ataia Medical positions itself as a niche player addressing the specific need for communication solutions in non-invasive ventilation.